Total Voting Rights

 

TIDMGWP 
 
RNS Number : 5739J 
GW Pharmaceuticals PLC 
31 March 2010 
 

 
       GW Pharmaceuticals PLC ("GW Pharmaceuticals"): Total voting rights 
 
 
 
Porton Down, UK, 31 March 2010: GW Pharmaceuticals (AIM: GWP) hereby provides 
notification of the following information for the purposes of Rule 5.6.1R of the 
Disclosure and Transparency Rules: 
 
GW Pharmaceuticals' issued share capital consists of 129,843,322 ordinary shares 
of 0.1p each with voting rights. There are no shares held in treasury. 
Therefore, the total number of voting rights in GW is 129,843,322. 
 
The above figure may be used by shareholders as the denominator for the 
calculations by which they will determine if they are required to notify their 
interest in, or a change to their interest in, GW Pharmaceuticals under the 
FSA's Disclosure and Transparency Rules. 
 
 
For further information, please contact: 
 
GW Pharmaceuticals PLC                                 [phone] 
Adam George, Company Secretary 
 
Piper Jaffray Ltd (Nominated Adviser) 
Neil Mackison/Rupert Winckler                          +44  (0) 203 142 8700 
 
Notes to Editors: 
 
About GW Pharmaceuticals 
 
GW Pharmaceuticals was founded in 1998 and listed on the AIM, a market of the 
London Stock Exchange, in June 2001. Operating under license from the UK Home 
Office, the company researches and develops cannabinoid pharmaceutical products 
for patients who suffer from a range of serious ailments, in particular multiple 
sclerosis and cancer pain. GW has assembled a large in-house scientific team 
with expertise in cannabinoid science as well as experience in the development 
of both plant-based prescription pharmaceutical products and medicines 
containing controlled substances. GW occupies a world leading position in 
cannabinoids and has developed an extensive international network of the most 
prominent scientists in the field. For more information, visit www.gwpharm.com 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TVRZMGFFVMNGGZM